These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 28343076)
1. Repression of DOK7 mediated by DNMT3A promotes the proliferation and invasion of KYSE410 and TE-12 ESCC cells. Yang SM; Li SY; Yu HB; Li JR; Sun LL Biomed Pharmacother; 2017 Jun; 90():93-99. PubMed ID: 28343076 [TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma. Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation. Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma. Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829 [TBL] [Abstract][Full Text] [Related]
5. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma. Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086 [TBL] [Abstract][Full Text] [Related]
7. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329 [TBL] [Abstract][Full Text] [Related]
8. IL-11 activated by lnc-ATB promotes cell proliferation and invasion in esophageal squamous cell cancer. Yang SM; Li SY; Hao-Bin Y; Lin-Yan X; Sheng X Biomed Pharmacother; 2019 Jun; 114():108835. PubMed ID: 30954889 [TBL] [Abstract][Full Text] [Related]
9. Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2'-deoxycytidine, in esophageal squamous cell carcinoma. Arai M; Imazeki F; Sakai Y; Mikata R; Tada M; Seki N; Shimada H; Ochiai T; Yokosuka O Oncol Rep; 2008 Aug; 20(2):405-12. PubMed ID: 18636205 [TBL] [Abstract][Full Text] [Related]
12. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma. Guo W; Wang C; Guo Y; Shen S; Guo X; Kuang G; Dong Z Clin Exp Metastasis; 2015 Jan; 32(1):83-98. PubMed ID: 25579665 [TBL] [Abstract][Full Text] [Related]
13. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
14. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma. He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785 [TBL] [Abstract][Full Text] [Related]
15. Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma. Guo W; Cui L; Wang C; Guo Y; Shen S; Kuang G; Dong Z Clin Exp Metastasis; 2014 Jun; 31(5):521-33. PubMed ID: 24756244 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma. Kwon J; Park M; Kim JH; Lee HW; Kang MC; Park JH Tumour Biol; 2015 Sep; 36(10):7449-56. PubMed ID: 25903467 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma. Meng XY; Zhu ST; Zong Y; Wang YJ; Li P; Zhang ST Dis Esophagus; 2011 Aug; 24(6):444-9. PubMed ID: 21166741 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma. Li P; Liu X; Dong ZM; Ling ZQ Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908 [TBL] [Abstract][Full Text] [Related]
19. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling. Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445 [TBL] [Abstract][Full Text] [Related]
20. Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK. Bai J; Zhang X; Hu K; Liu B; Wang H; Li A; Lin F; Zhang L; Sun X; Du Z; Song J Oncotarget; 2016 Jul; 7(28):44129-44141. PubMed ID: 27286455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]